Friday, July 31, 2026

1:45 PM - 3:00 PM

Pyrmont Theatre

---

Overview

Dr Dorota Pawlak - Chief Scientific Officer and Director | Breakthrough T1D

---

Details

Type 1 diabetes isn’t slowing down, and neither are the 135,000 Australians living with it. Around 10 per cent of all diabetes cases and 3,000 new diagnoses every year mean the challenge keeps growing, but so does the tech. Continuous glucose monitors, smart insulin delivery and algorithm-driven care are redefining what “control” even means. Welcome to the world of Type 1 in 2026! A world of data, devices and digital determination. This opening masterclass session looks at how pharmacists can keep up with the pace, decode the data and lead conversations that go way beyond blood glucose levels. Expect a look into the future of diabetes care that’s more connected and more human. Learning objectives: • Identify current best practice recommendations for type 1 diabetes management. • Discuss the pharmacist’s role in supporting insulin titration, glucose monitoring, and patient self-management. • Describe how emerging technologies and therapies are influencing outcomes in type 1 diabetes. Competency Standards (2016): 1.5, 3.5

---

Speakers